• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SMITHS HEALTHCARE MANUFACTURING S.A. DE C.V. CLEO INSULIN SET; SET, ADMINISTRATION, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SMITHS HEALTHCARE MANUFACTURING S.A. DE C.V. CLEO INSULIN SET; SET, ADMINISTRATION, INTRAVASCULAR Back to Search Results
Catalog Number 21-7231-24
Medical Device Problem Codes Break (1069); Material Deformation (2976); Physical Resistance/Sticking (4012)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 01/01/2025
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
A supplemental mdr will be filed as necessary in accordance with 21 cfr 803.56 when additional reportable information becomes available.
 
Event or Problem Description
It was reported that the insertion aid could only be removed with the help of another person and this occasionally bent the tube and led to the error messages during insulin release.The message ¿tube blocked¿ appeared although 20 units were still included.The issue occurred immediately upon use.There was no harm/adverse event reported.
 
Additional Manufacturer Narrative
H6: evaluation codes updated.Device evaluation: one sample was received.As received, the cannula tubing was observed to be deformed.No other damages or anomalies were observed.The complaint of cannula breakage can be confirmed.The complaint of strong adhesion cannot be confirmed nor replicated.The complaint of pump occlusion cannot be confirmed nor replicated due to the catheter and pump not being returned for a full comprehensive evaluation.The product's history records were reviewed and there were no non-conformances nor service-related issues that would have resulted in the reported complaint.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CLEO INSULIN SET
Common Device Name
SET, ADMINISTRATION, INTRAVASCULAR
Manufacturer (Section D)
SMITHS HEALTHCARE MANUFACTURING S.A. DE C.V.
ave calidad no. 4, parque
tijuana
MX 
Manufacturer Contact
reed covert
6000 nathan ln n
minneapolis, MN 55442
2247062300
MDR Report Key21269882
Report Number3012307300-2025-01318
Device Sequence Number15492998
Product Code FPA
UDI-Device Identifier30610586028407
UDI-Public(01)30610586028407(17)270908(10)4321046
Combination Product (Y/N)N
Initial Reporter CountryGM
PMA/510(K) Number
K042172
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,User Facility
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date (Section B) 04/04/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue Number21-7231-24
Device Lot Number4321046
Was Device Available for Evaluation? Yes
Date Returned to Manufacturer01/28/2025
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 01/07/2025
Supplement Date Received by Manufacturer03/10/2025
Initial Report FDA Received Date01/29/2025
Supplement Report FDA Received Date04/04/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured09/28/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-